Document:

FINDER'S AGREEMENT

THIS AGREEMENT made on 17th day of August,  1999, by and between AVALON RESEARCH
GROUP INC. ("AVALON") and COMMODORE APPLIED TECHNOLOGIES, INC. ("CXI"),

1.   THE PARTIES

     1.1  CXI, a corporation, with its principal office at 150 East 58th Street,
          Suite  3400,  New  York,  Now  York  10155  (tel.:  212-308-5800;  fax
          212-753-0731).

     1.2  AVALON, a corporation,  with its principal office at 1900 Glades Road,
          Suite  201,  Boca  Raton,  Florida  88481  (tel.:  561-447-4044;  fax:
          561-447-4042; email; acchen@avalonresearch.com.

     1.3  The persons executing this Agreement represent that they have full and
          complete  authority  to enter into this  Agreement  on behalf of their
          respective companies.

2.   THE AGREEMENT

     2.1  CXI seeks a purchaser of all or part of a private  placement  offering
          (`Offering").  The  offering  shall be for any  combination  of equity
          and/or debt on terms and conditions  satisfactory  to CXI. As a result
          of the  introduction  made  through  AVALON to a buyer of the Offering
          (referred  to herein  as  "INVESTORS")  or any  related  entity  under
          INVESTORS'  control,  should the  Offering  be closed  with  INVESTORS
          within  one year,  hereof,  CXI shall owe  AVALON  the fees  described
          herein.  Should CXI close on any  introduced  transactions  under this
          Agreement,  that in itself  shall serve as proof that the Offering met
          the terms and conditions that were satisfactory to CXI.

     2.2  It is  acknowledged  by CXI that:  AVALON has acted solely as a finder
          and not in any  other  capacity;  AVALON  has not  advised  CXI in any
          manner regarding the merits of this or any other transaction;  CXI has
          consulted its own counsel on all aspects of this Offering and has done
          its own due  diligence  to its  satisfaction;  AVALON has not made any
          representations to CXI.

<PAGE>

     2.3  AVALON is a NASD broker/dealer and NASDAQ Market Maker.  INVESTORS may
          be clients of AVALON.  AVALON may make a market in CXI. AVALON, or its
          clients, may have positions or trade in CXI at any time.

     2.4  CXI  shall  be  under no  obligation  to pay any fee or  other  monies
          whatsoever  to AVALON on  account  of this  Agreement  unless  (a) the
          purchase of the Offering  contemplated  by this  Agreement  has closed
          with  INVESTORS and (b) the purchase of the Offering has resulted from
          the introduction by AVALON to CXI of INVESTORS.

     2.5  Prior to  introduction to any particular  investor,  AVALON will first
          disclose the identity of that  proposed  investor to CXI.  CXI, at its
          sole discretion,  can approve or decline whether such introduction can
          be made to that investor.  If CXI does not approve or decline  whether
          such  introduction can be made to that investor within 24 hours of the
          disclosure  of the  identity of that  investor by AVALON to CXI,  then
          such inaction shall be deemed an approval.

     2.6  This  Agreement  will  expire  sixty days from the date first above at
          which time neither party will have any  obligations  towards the other
          party unless introduced INVESTORS are actively negotiating with CXI at
          expiration  time,  then this Agreement will survive until such time as
          the active dealings either terminate or an Offering is dosed.

3.   TEE FEE

     3.1  In  consideration  of its services,  AVALON shall be paid by CXI a sum
          equal to Ten Percent (10%) of all funds raised upon the closing of the
          transaction,  The term "funds  raised"  shall include all funds due to
          CXI under the Agreement  between CXI and INVESTORS  regardless of when
          those funds may be payable to CXI.

     3.2  In addition to the cash fee in paragraph 3.1,  AVALON shell be granted
          100,000 common stock  purchase  warrants  ("Warrants")  per $1 million
          raised, or such part thereof as pro-rated. The

                                                                               2

<PAGE>

          Warrants  shall have an exercise  price of 110% of the average  dosing
          price of the common stock over the 5-day trading  period ending on the
          day prior to the closing of this Offering (as reported by  Bloomberg).
          Such  Warrants  shall  expire five years from the closing  date of the
          Offering end shall piggyback on the next  registration  statement made
          after issue of the Warrants.

     3.3  The fee due to AVALON  shall be  payable  to AVALON  through an escrow
          account at closing at the same time as the funds are  released  to CXI
          and the stock certificates are released to INVESTORS. The Warrants due
          to AVALON  shall be  payable  to AVALON not later than sixty days from
          the date of  closing.  If CXI fails to issue the  Warrants as per this
          paragraph,  AVALON shall be entitled to a penalty of an additional 10%
          of the amount of the  Warrants  due per  calendar  quarter  until such
          Warrants are issued.  The additional  Warrants to be granted under the
          penalty provision herein shall not be prorated.

4.   OTHER

     41.  In the event of any dispute  between CXI and AVALON  arising  under or
          pursuant  to the terms of this  Agreement,  the same  shall be settled
          only by arbitration in the County of Palm Beach, State of Florida,  in
          accordance with the rules and regulations of the American  Arbitration
          Association.  The  determination of the arbitrators shall be final and
          binding  upon  CXI and  AVALON  and may be  enforced  in any  court of
          appropriate jurisdiction.

     4.2  This  Agreement  shall be construed by and governed  under the laws of
          the State of Florida.

     4.3  This Agreement  contains the entire  agreement  between AVALON and CXI
          concerning  the  introduction  of INVESTORS to CXI and correctly  sets
          forth the rights and duties of each of the parties to each other.  Any
          agreement  or  representation  concerning  the subject  matter of this
          Agreement or the duties of AVALON to CXI in relation thereto,  not set
          forth in this Agreement, is null and void.

                                                                               3

<PAGE>

IN WITNESS  WHEREOF,  the parties  have signed this  Agreement on the date first
written above.

                                        COMMDODORE APPLIED TECHNOLOGIES. INC.

                                        By:  /s/  Paul E. Hannesson
                                             ----------------------------------
                                             Paul E. Hannesson, Chairman

                                        AVALON RESEARCH GROUP, INC.

                                        By:  /s/  Adam B. Cohen
                                             ----------------------------------
                                             Adam B. Cohen, General Counsel

                                                                               4Exhibit 10.6

                              SPONSORSHIP AGREEMENT

     This Sponsorship Agreement (the "Agreement") is entered into as of the 16th
day of August, 1999 (the "Effective Date") by and between drkoop.com inc., a
Texas corporation, located at 8920 Business Park Drive, Longhorn Suite, Austin,
Texas 78759 ("drkoop.com"), and Nutrisystem, a [Pennsylvania] corporation,
located at 202 Welsh Road, Horsham, PA 19044 ("Sponsor").

                                    RECITALS

     WHEREAS, drkoop.com inc develops, markets and maintains an integrated suite
of Internet enabled, consumer oriented software applications and services,
including but not limited to, drkoop.com, electronic data interchange services,
and advertising and promotional services on the Internet at the website
http://www.drkoop.com (the "drkoop.com Website");

     WHEREAS, Sponsor markets and sells weight loss management systems.

                                    AGREEMENT

     NOW, THEREFORE, in consideration of the mutual covenants and promises
contained herein and for other good and valuable consideration the receipt and
adequacy of which are hereby acknowledged, the parties hereto agree as follows:

                              SPONSORSHIP SERVICES

     During the term of this agreement, drkoop.com agrees to provide Sponsor
with the advertising and/or sponsorship services described in Appendix A.

                                   ARTICLE I.
                               SPONSORSHIP POLICY

     1.1. Content. Sponsor shall provide advertising and logo content (the
"Advertising Content") in accordance with the specifications set forth on
Exhibit B attached hereto. DRKOOP.COM reserves the right, without liability, and
at its sole discretion, to exclude any Advertisement Content or to terminate
any links that drkoop.com deems inappropriate.

     1.2. Changes and Cancellations. Any cancellations or change orders must be
made in writing and acknowledged by DRKOOP.COM. Sponsor shall not be required
to change Advertising Content more often than once per month. Sponsor shall
provide DRKOOP.COM with Advertising Content artwork at least five business days
in advance of the publication date.

     1.3. Statistics. DRKOOP.COM shall provide Sponsor with Sponsor usage
statistics on a monthly basis. Sponsor shall have the right to use such data for
its internal business purposes, but may not provide such data for use by third
parties.

                                       S-1

<PAGE>

     1.4. Publication Error. In the event of a publication error in the
Advertising Content arising exclusively from the fault of DRKOOP.COM, Sponsor
shall notify DRKOOP.COM of such error and DRKOOP.COM will use reasonable efforts
to promptly correct the error. DRKOOP.COM 's sole obligation and liability for
such publication errors shall be to use reasonable efforts to promptly correct
such errors.

     1.5. Payment.

     1.5.1. Fees. In consideration for the Services, Sponsor shall pay
DRKOOP.COM the fee of $[     ] (the "Fees") as follows. Such Fees shall be paid
in one payment of $[     ] at the effective date of the agreement term and
twelve (12) consecutive monthly installments of $[     ], with the first monthly
payment due and payable one month from the commencement of delivery of
advertising services.

     1.5.2. Taxes. Sponsor shall be responsible for the collection of any and
all value added, consumption, sales, use or similar taxes and fees payable with
respect to the Services and shall pay such collected taxes to the relevant tax
authorities.

                                   ARTICLE II.
                                OWNERSHIP OF DATA

     2.1. User Data. Drkoop.com requests its users ("Individual Users"), to
provide personal information when they sign up for certain services including
requesting information on a specific disease, chat rooms and forums ("User
Data"). Such User Data is owned by each Individual User and drkoop.com does not
use or disclose any such User Data without the consent of the Individual User.

     2.2. Data Release to Sponsor. Drkoop.com shall provide to Sponsor any and
all User Data for which the Individual User has specifically authorized release
to Sponsor. All other user data would be available on an aggregate basis. In the
event that an Individual User grants rights to Sponsor for use of his User Data,
Sponsor shall use its best efforts to keep User Data confidential and shall only
use such data in an ethical manner. Sponsor may use User Data for its own
purposes, but User Data may not be disclosed, sold, assigned, leased or
otherwise disposed of to third parties by Sponsor.

     2.3. Data Confidentiality. The User Data shall be drkoop.com Confidential
Information under Article 5 and shall in addition be subject to the terms of
this Article 3. Sponsor shall be liable for the conduct of its employees, agents
and representatives who in any way breach this Amendment. Sponsor's obligations
to treat the User Data as Confidential Information under Article 5 and this
Article 3 shall continue in perpetuity following termination of this Amendment.

                                  ARTICLE III.
                                     LICENSE

     3.1. License. Sponsor grants to drkoop.com a non-exclusive, limited right
and license to use and display the Advertising Content for the sole purpose of
providing the Services. Sponsor

                                       S-2

<PAGE>

shall retain all right, title, and interest (including all copyrights, service
marks, trademarks and other intellectual property rights) in the Advertising
Content and drkoop.com shall not acquire any interest therein.

     3.2. Intellectual Property Ownership. Drkoop.com shall retain all right,
title and interest (including all copyrights, patents, service marks, trademarks
and other intellectual property rights) in the drkoop.com Web Site. Except for
the license granted pursuant to this Agreement, Sponsor shall not acquire any
interest in the drkoop.com Web Site or any other services or materials, or any
copies or portions thereof, provided by drkoop.com pursuant to this Agreement.

     3.3. Use of Name and Likeness. Sponsor shall not have any right to use the
name and/or likeness of Dr. C. Everett Koop or to make any statements, whether
written or oral, which state or otherwise imply, directly or indirectly, any
endorsement from or affiliation with Dr. Koop in any manner whatsoever without
the prior written consent of DRKOOP.COM, which consent may be withheld in
DRKOOP.COM's sole discretion.

                                   ARTICLE IV.
                                 CONFIDENTIALITY

     4.1. Confidentiality. For the purposes of this Agreement, "Confidential
Information" means non-public information about the disclosing party's business
or activities that is proprietary and confidential, which shall include, without
limitation, all business, financial, technical and other information of a party
marked or designated "confidential" or by its nature or the circumstances
surrounding its disclosure should reasonably be regarded as confidential.
Confidential Information includes not only written or other tangible
information, but also information transferred orally, visually, electronically
or by any other means. Confidential Information will not include information
that (i) is in or enters the public domain without breach of this Agreement,
(ii) the receiving party lawfully receives from a third party without
restriction on disclosure and without breach of a nondisclosure obligation or
(iii) the receiving party knew prior to receiving such information from the
disclosing party or develops independently.

     4.2. Exclusions. Each party agrees (i) that it will not disclose to any
third party or use any Confidential Information disclosed to it by the other
except as expressly permitted in this Agreement and (ii) that it will take all
reasonable measures to maintain the confidentiality of all Confidential
Information of the other party in its possession or control, which will in no
event be less than the measures it uses to maintain the confidentiality of its
own information of similar importance.

     4.3. Exceptions. Notwithstanding the foregoing, each party may disclose
Confidential Information (i) to the extent required by a court of competent
jurisdiction or other governmental authority or otherwise as required by law or
(ii) on a "need-to-know" basis under an obligation of confidentiality to its
legal counsel, accountants, banks and other financing sources and their
advisors. Except as set forth in this Section 5.3, the terms and conditions of
the Agreement will be deemed to be the Confidential Information of each party
and will not be disclosed without the prior written consent of the other party.

                                       S-3

<PAGE>

                                   ARTICLE V.
                 REPRESENTATIONS AND WARRANTIES; INDEMNIFICATION

     5.1. Sponsor Warranty. Sponsor represents and warrants for the benefit of
DRKOOP.COM that the Advertising Content is true and correct and does not and
will not for the term of this Agreement infringe upon or violate: (i) any
copyright of any third party and does not and will not constitute a defamation
or invasion of the rights of privacy or publicity of any kind of any third
party, (ii) any applicable law, regulation or non-proprietary third-party right.
Sponsor further represents and warrants for the benefit of DRKOOP.COM that the
Advertising Content does not contain any material which is unlawful, harmful,
abusive, hateful, obscene, threatening or defamatory and Sponsor is not an
entity or an affiliate of any entity which engages in the manufacture or
wholesale distribution of tobacco or tobacco products (such activities are
collectively referred to herein as "Tobacco Industry Affiliation").

     5.2. Indemnification By Sponsor. Sponsor agrees to indemnify and hold
harmless DRKOOP.COM, its officers, directors, employees, and agents from and
against any claims, demands, causes of action and judgments (including
reasonable attorneys' fees and court costs) (collectively, "DRKOOP.COM Claims")
by any third party rising out of any breach or alleged breach of any of Sponsor'
representations and warranties contained in this Section 6.1, provided that
DRKOOP.COM gives Sponsor prompt written notice of the assertion of any such
DRKOOP.COM Claim Sponsor shall have the option to undertake and control the
defense and settlement of any such DRKOOP.COM Claim; provided, however, that (i)
DRKOOP.COM may participate in any such proceeding at its own expense with
counsel of its own choosing, and (ii) Sponsor shall not settle any such
DRKOOP.COM Claim in a manner that adversely affects DRKOOP.COM unless DRKOOP.COM
agrees to such settlement in writing.

                                   ARTICLE VI.
                             LIMITATION OF LIABILITY

     6.1. Warranty. DRKOOP.COM will use commercially reasonable efforts to
maintain the DRKOOP.COM Website available and display the Advertising Content
twenty four hours per day each day during the term of the Agreement. DRKOOP.COM
shall install and maintain a commercially acceptable system of collecting
information about Impressions and other data relating to the use of the
Advertising Content. DRKOOP.COM warrants to Sponsor that it will make reasonable
effort to perform the Services in a competent manner.

     6.2. Exclusion of Warranty. EXCEPT AS EXPRESSLY SET FORTH IN THIS
AGREEMENT, DRKOOP.COM MAKES NO WARRANTY IN CONNECTION WITH THE SUBJECT MATTER OF
THIS AGREEMENT AND HEREBY DISCLAIMS ANY AND ALL WARRANTIES WITH REGARD TO
DRKOOP.COM'S WEBSITE AND SERVICES, EXPRESS OR IMPLIED, INCLUDING WITHOUT
LIMITATION, ANY WARRANTY OF NONINFRINGEMENT AND THE IMPLIED WARRANTIES OF
MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE. IN PARTICULAR, AND NOT BY
WAY OF LIMITATION, DRKOOP.COM DOES NOT WARRANT THAT ITS WEBSITE WILL OPERATE
ERROR-FREE OR WITHOUT INTERRUPTION.

                                       S-4

<PAGE>

     6.3. Damages. IN NO EVENT SHALL DRKOOP.COM BE LIABLE TO SPONSOR FOR ANY
SPECIAL, INCIDENTAL, CONSEQUENTIAL OR PUNITIVE DAMAGES ARISING OUT OF THIS
AGREEMENT OR ITS TERMINATION, WHETHER LIABILITY IS ASSERTED IN CONTRACT, TORT
(INCLUDING NEGLIGENCE) STRICT LIABILITY OR OTHERWISE AND IRRESPECTIVE OF WHETHER
DRKOOP.COM HAS BEEN ADVISED OF THE POSSIBILITY OF ANY SUCH LOSS OR DAMAGE.
Notwithstanding the foregoing, in no event shall DRKOOP.COM's cumulative
liability under this Agreement exceed the amount actually paid by Sponsor to
DRKOOP.COM in the immediately preceding six (6) month period.

                                  ARTICLE VII.
                              TERM AND TERMINATION

     7.1. Term; Termination. This Agreement will remain in effect from the
effective date to one year after implementation of advertising services to
sponsor. Implementation of advertising services will commence on October 1,
1999. Upon completion of the agreement term, sponsor retains the right of first
refusal for the premier sponsorship of the weight management center on
www.drkoop.com.

     7.2. Termination for Tobacco Industry Affiliation. Upon commencing any
activities relating to Tobacco Industry Affiliation (as defined in Section 6.1),
Sponsor shall promptly notify DRKOOP.COM of its intent to undertake Tobacco
Industry Affiliation. Upon receipt of such notice or upon learning of any such
Tobacco Industry Affiliation from a third party, DRKOOP.COM shall have the right
to terminate this Agreement immediately on written notice to Sponsor without
liability of any kind.

     7.3. Termination for Cause. Either party may terminate this Agreement upon
thirty (30) days' written notice of a breach by the other party, provided such
breach is not cured within such thirty-day period.

     7.4. Termination by Insolvency. Either party may terminate this Agreement
by providing written notice to the other party if the other party ceases to
function as a going concern, becomes insolvent, makes an assignment for the
benefit of creditors, files a petition in bankruptcy, permits a petition in
bankruptcy to be filed against it, or admits in writing its inability to pay its
debts as they mature, or if a receiver is appointed for a substantial part of
its assets.

     7.5. Survival. The following Sections shall survive termination of this
Agreement: Section ___, Article 5 (Confidentiality), Article 6
(Indemnification), Article 6 (Limitation of Liability), Section 7.5 (Effect of
Termination) and Article 9 (General). [NEED TO UPDATE]

                                       S-5

<PAGE>

                                  ARTICLE VIII.
                                     GENERAL

     8.1. Publicity. Except as may be required by applicable laws and
regulations or a court of competent jurisdiction, or as required to meet credit
and financing arrangements, or as required or appropriate in the reasonable
judgment of either party to satisfy the disclosure requirements of an applicable
securities law or regulation or any applicable accounting standard, neither
party shall make any public release respecting this Agreement and the terms
hereof without the prior consent of the other party.

     8.2. Arbitration. Any and all disputes, controversies and claims arising
out of or relating to this Agreement or concerning the respective rights or
obligations of the parties hereto shall be settled and determined by arbitration
in Austin, Texas before one (1) arbitrator pursuant to the Commercial Rules then
in effect of the American Arbitration Association. Each party shall have no
longer than three (3) days to present its position. Judgment upon the award
rendered may be entered in any court having jurisdiction or application may be
made to such court for a judicial acceptance of the award and an order of
enforcement. The parties agree that the arbitrators shall have the power to
award damages, injunctive relief and reasonable attorneys' fees and expenses to
any party in such arbitration.

     8.3. Assignment. Neither party may assign this Agreement, in whole or in
part, without the other party's written consent, which consent will not be
unreasonably withheld, except that a party's rights hereunder may be transferred
to a successor of all or substantially all of the business and assets of the
party regardless of how the transaction or series of related transactions is
structured.

     8.4. Governing Law. This Agreement shall be construed and enforced in
accordance with the laws of the State of Delaware, but without giving effect to
its laws or rules relating to conflicts of laws.

     8.5. Notice. All notices, statements and reports required or permitted by
this Agreement shall be in writing and deemed to have been effectively given and
received: (i) five (5) business days after the date of mailing if sent by
registered or certified U.S. mail, postage prepaid, with return receipt
requested; (ii) when transmitted if sent by facsimile, provided a confirmation
of transmission is produced by the sending machine and a copy of such facsimile
is promptly sent by another means specified in this section; or (iii) when
delivered if delivered personally or sent by express courier service. Notices
shall be addressed as follows:

     For DRKOOP.COM:                           For Sponsor:

           Drkoop.com Inc.                            Nutrisystem

           8920 Business Park Drive                   202 Welsh Road
           Austin, TX  78759
           Attn:  Chief Financial Officer             Horsham, PA  19044

                                       S-6

<PAGE>

                                                     Attn:  Brian Haveson

                                                     President

Either party may change its address for the purpose of this paragraph by notice
given pursuant to this paragraph.

     8.6. No Agency. The parties are independent contractors and will have no
power or authority to assume or create any obligation or responsibility on
behalf of each other. This Agreement will not be construed to create or imply
any partnership, agency or joint venture.

     8.7. Severability. In the event that any of the provisions of this
Agreement are held to be unenforceable by a court or arbitrator, the remaining
portions of the Agreement will remain in full force and effect.

     8.8. Entire Agreement. This Agreement is the complete and exclusive
agreement between the parties with respect to the subject matter hereof,
superseding any prior agreements and communications (both written and oral)
regarding such subject matter. This Agreement may only be modified, or any
rights under it waived, by a written document executed by both parties.

     8.9. Counterparts. This Agreement may be signed in counterparts which, when
signed, shall constitute one document.

     IN WITNESS WHEREOF, the parties have caused this Agreement to be duly
executed and delivered as of the day and year first above written.

                                        ACCEPTED BY:

                                        Drkoop.com inc.

                                        By: /s/ Susan Georgen-Saad
                                            ------------------------------
                                             Name: Susan Georgen-Saad
                                             Title: CFO

                                        Nutrisystem

                                        By: /s/ Brian Haveson
                                            ------------------------------
                                            Name:  Brian Haveson
                                            Title:  President

                                       S-7

<PAGE>

                                    EXHIBIT A

                              Advertising Services

1. Nutrisystem shall be the premier sponsor of 75% of the content within the
   Weight Management Center on www.drkoop.com public site.

2. Drkoop.com shall not display banner advertising on the Weight Management
   Center from any direct competitor. Drkoop.com shall not display a direct
   competitor's logo button on the drkoop.com home page when the sponsor's logo
   is simultaneously being presented. As used herein, "Director Competitor"
   shall meany any company whose primary function is the administration of
   weight loss programs. This does not include companies whose primary function
   is to manufacture or distribute nutritional products that may be used as a
   part of a weight management program. Sponsor has designated that "Direct
   Competitors" will include but are not limited to: 1) Jenny Craig Inc., 2)
   Ediets.com 3) Weight Watchers International, Incorporated.

3. Nutrisystem will be noted as sponsor of the Weight Management Center on 75%
   of the content within the Weight Management Center on www.drkoop.com public
   site.

4. Drkoop.com will deliver the following number of advertising impressions over
   the sponsorship term.-15,952,000. If drkoop.com does not deliver the
   designated amount of impressions in the weight management center, agreement
   term will be extended till impressions have been delivered.

5. Sponsor advertising impressions will be distributed in the following areas:

   -  Category Placements - 468 x 60 banners and linkable sponsor logos located
      in the Weight Management Center - 6,984,000

   -  Community Placements - 468 x 60 banners in Chat group areas, promotion of
      spotlight events.  Text links in spotlight events. - 166,200

   -  Value Added Placements - Home page logo buttons, Sponsorship of drkoop.com
      newsletter (2), 468 x 60 banners in Dr. Nancy Snyderman, Health and
      Wellness and Women's health content areas. - 7,577,000

   -  Run of Site placements - 120 x 60 and 468 x 60 banners placed throughout
      drkoop.com at the discretion of drkoop.com. - 1,200,000

   -  Pre launch impressions - 120 x 60 and 468 x 60 banners on the drkoop.com
      home page and fitness center. - 175,000

                                       A-1

<PAGE>

                                    EXHIBIT B

                TECHNICAL SPECIFICATIONS FOR ADVERTISING ELEMENTS

File Formats

Naming Convention: (lowercase only, 8.3)

Alternate Text: Use ALT tag; ten words or less

Image Dimensions:

Sponsor Banner: 468 pixels by 60 pixels, 120 pixels by 60 pixels (no animation
on 120 x 60 banners)

Home page logo: 88 pixels by 31 pixels, (size subject to change with
reformatting of home page)

Image File Format: [GIF/JPEG]

Image File Size: 12 k maximum file size

File Names: Use Sponsor name.: [Sponsor].gif]

Delivery of GIFs

Email - mbaehr@drkoop.com, cc: gsears@drkoop.com

We accept [,CompactPro, zip, gzip, and UNIX tar or compress] format tiles. All
formats must be mailed in [ASCII encoding(uuencode, mmencode)].

                                       B-1

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00001-of-00352.parquet"}]]